𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A 52-week randomized safety study of a calcipotriol/betamethasone dipropionate two-compound product (Dovobet®/Daivobet®/Taclonex®) in the treatment of psoriasis vulgaris

✍ Scribed by K. Kragballe; J. Austad; L. Barnes; A. Bibby; M. De La Brassinne; F. Cambazard; C. Fleming; H. Heikkilä; D. Jolliffe; J. Peyri; Å. Svensson; J. Toole; G. Wozel


Book ID
108668792
Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
160 KB
Volume
154
Category
Article
ISSN
0007-0963

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Comparison of calcipotriol monotherapy a
✍ Ruzicka; Lorenz 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 848 KB

A clinical study was conducted to determine whether, in the topical treatment of psoriasis, a combination of calcipotriol and betamethasone valerate after previous treatment with calcipotriol alone was more effective than the continuation of the monotherapy with calcipotriol, especially in 'low resp

Efficacy and safety of a new combination
✍ L. Guenther; F. Cambazard; P.C.M. Van De Kerkhof; E. Snellman; K. Kragballe; A. 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 124 KB

## Background: Calcipotriol and betamethasone dipropionate are both widely used, effective treatments for psoriasis. vitamin d analogues and topical corticosteroids have different mechanisms of action in the treatment of psoriasis. a new vehicle has been developed in order to contain both calcipotr